C4 Therapeutics Appoints CSO
This article was originally published in Scrip
C4 Therapeutics has appointed Andrew Phillips chief scientific officer; he joins the company from the Broad Institute of MIT and Harvard where he was senior director, center for development of therapeutics. Previously he was a professor of chemistry at Yale University.
Register for our free email digests: